(812238, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812239, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812240, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812241, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812242, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812243, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812244, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812245, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812246, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812247, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812248, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812249, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812250, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812251, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812252, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812253, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812254, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812255, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812256, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812257, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812258, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812259, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812260, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812261, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812262, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812263, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812264, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812265, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812266, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812267, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812268, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812269, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812270, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812271, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812272, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812273, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812274, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812275, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812276, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812277, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812278, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812279, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812280, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812281, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812282, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812283, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812284, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812285, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812286, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812287, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812288, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812289, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812290, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812291, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812292, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812293, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812294, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812295, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812296, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812297, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812298, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812299, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812300, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812301, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812302, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812303, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812304, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812305, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812306, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812307, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812308, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812309, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812310, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812311, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812312, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812313, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812314, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812315, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812316, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812317, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812318, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812319, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812320, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812321, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812322, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812323, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812324, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812325, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812326, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812327, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812328, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812329, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812330, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812331, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812332, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812333, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812334, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812335, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812336, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812337, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812338, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812339, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812340, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812341, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812342, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812343, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812344, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812345, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812346, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812347, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812348, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812349, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812350, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812351, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812352, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812353, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812354, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812355, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812356, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812357, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812358, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812359, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812360, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812361, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812362, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812363, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812364, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812365, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812366, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812367, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812368, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812369, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812370, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812371, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812372, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812373, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812374, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812375, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812376, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812377, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812378, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812379, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812380, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812381, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812382, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812383, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812384, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812385, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812386, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812387, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812388, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812389, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812390, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812391, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812392, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812393, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812394, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812395, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812396, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812397, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812398, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812399, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812400, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812401, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812402, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812403, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812404, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812405, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812406, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812407, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812408, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812409, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812410, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812411, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812412, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812413, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812414, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812415, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812416, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812417, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812418, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812419, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812420, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812421, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812422, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812423, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812424, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812425, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812426, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812427, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812428, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812429, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812430, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812431, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812432, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812433, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812434, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812435, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812436, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812437, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812438, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812439, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812440, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812441, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812442, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812443, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812444, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812445, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812446, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812447, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812448, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812449, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812450, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812451, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812452, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812453, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812454, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812455, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812456, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812457, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812458, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812459, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812460, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812461, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812462, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812463, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812464, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812465, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812466, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812467, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812468, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812469, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812470, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812471, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812472, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812473, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812474, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812475, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812476, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812477, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812478, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812479, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812480, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812481, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812482, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812483, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812484, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812485, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812486, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812487, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812488, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812489, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812490, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812491, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812492, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812493, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812494, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812495, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812496, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812497, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812498, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812499, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812500, 'HP:0005429', 'Recurrent systemic pyogenic infections', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812501, 'HP:0008049', 'Abnormality of the extraocular muscles', 'MP:0030063', 'abnormal face size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(812502, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0011510', 'biventricular, discordant atrioventricular connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812503, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000644', 'dextrocardia', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812504, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0004110', 'transposition of great arteries', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812505, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010434', 'double inlet heart right ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812506, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000284', 'double outlet right ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812507, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0003279', 'aneurysm', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812508, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0004032', 'abnormal interventricular groove morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812509, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812510, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010440', 'anomalous pulmonary venous connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812511, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(812512, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000266', 'abnormal heart morphology', 0.46153846153846156, 7.506484928906078, 1.8613252014758086, 'UPHENO:0076810', 'abnormal heart morphology'),
(812513, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012688', 'abnormal heart ventricles weight', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812514, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0011511', 'biventricular, ambiguous atrioventricular connection', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812515, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010426', 'abnormal heart and great artery attachment', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812516, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0003141', 'cardiac fibrosis', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812517, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010433', 'double inlet heart left ventricle', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812518, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012687', 'abnormal heart atrium weight', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812519, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0013332', 'peliosis', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812520, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012515', 'abnormal heart apex morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812521, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812522, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000288', 'abnormal pericardium morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812523, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0005294', 'abnormal heart ventricle morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812524, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0006065', 'abnormal heart position or orientation', 0.43333333333333335, 7.506484928906078, 1.8035548607844731, 'UPHENO:0076810', 'abnormal heart morphology'),
(812525, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000650', 'mesocardia', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812526, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010409', 'cor triatriatum', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812527, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0005406', 'abnormal heart size', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812528, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0002838', 'decreased susceptibility to dystrophic cardiac calcinosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812529, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010545', 'abnormal heart layer morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812530, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0003105', 'abnormal heart atrium morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812531, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010224', 'abnormal heart ventricle outflow tract morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812532, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(812533, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010478', 'intracranial aneurysm', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812534, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010427', 'double outlet left ventricle', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812535, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812536, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0002839', 'increased susceptibility to dystrophic cardiac calcinosis', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812537, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0011648', 'thick heart valve cusps', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812538, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0006113', 'abnormal heart septum morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812539, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010442', 'partial anomalous pulmonary venous connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812540, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000267', 'abnormal heart development', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812541, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4074074074074074, 5.978701727774094, 1.5606945154560616, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812542, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.44, 5.978701727774094, 1.6219213175183935, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812543, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0003228', 'abnormal sinus venosus morphology', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812544, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000292', 'distended pericardium', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812545, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0011660', 'ectopia cordis', 0.41935483870967744, 7.506484928906078, 1.774226810934282, 'UPHENO:0076810', 'abnormal heart morphology'),
(812546, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0005608', 'cardiac interstitial fibrosis', 0.40625, 7.506484928906078, 1.7462844849474253, 'UPHENO:0076810', 'abnormal heart morphology'),
(812547, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012700', 'abnormal endocardial heart tube morphology', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812548, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010441', 'total anomalous pulmonary venous connection', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812549, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0000285', 'abnormal heart valve morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812550, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0006126', 'abnormal cardiac outflow tract development', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812551, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0010551', 'abnormal coronary vessel morphology', 0.42857142857142855, 7.506484928906078, 1.7936178437814383, 'UPHENO:0076810', 'abnormal heart morphology'),
(812552, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.4444444444444444, 7.506484928906078, 1.8265310082115378, 'UPHENO:0076810', 'abnormal heart morphology'),
(812553, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0012082', 'delayed heart development', 0.41379310344827586, 7.506484928906078, 1.7624221102561544, 'UPHENO:0076810', 'abnormal heart morphology'),
(812554, 'HP:0011552', 'Ambiguous atrioventricular connection', 'MP:0002925', 'abnormal cardiovascular development', 0.4230769230769231, 5.978701727774094, 1.5904247014496937, 'UPHENO:0076776', 'abnormal cardiovascular system morphology'),
(812555, 'HP:0010781', 'Skin dimple', 'MP:0001216', 'abnormal epidermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812556, 'HP:0010781', 'Skin dimple', 'MP:0001202', 'skin photosensitivity', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812557, 'HP:0010781', 'Skin dimple', 'MP:0001196', 'shiny skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812558, 'HP:0010781', 'Skin dimple', 'MP:0002897', 'blotchy skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812559, 'HP:0010781', 'Skin dimple', 'MP:0012078', 'abnormal tail ring morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812560, 'HP:0010781', 'Skin dimple', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812561, 'HP:0010781', 'Skin dimple', 'MP:0009606', 'increased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812562, 'HP:0010781', 'Skin dimple', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812563, 'HP:0010781', 'Skin dimple', 'MP:0001243', 'abnormal dermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812564, 'HP:0010781', 'Skin dimple', 'MP:0010285', 'decreased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812565, 'HP:0010781', 'Skin dimple', 'MP:0009605', 'decreased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812566, 'HP:0010781', 'Skin dimple', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812567, 'HP:0010781', 'Skin dimple', 'MP:0005501', 'abnormal skin physiology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(812568, 'HP:0010781', 'Skin dimple', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812569, 'HP:0010781', 'Skin dimple', 'MP:0001192', 'scaly skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812570, 'HP:0010781', 'Skin dimple', 'MP:0001211', 'wrinkled skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812571, 'HP:0010781', 'Skin dimple', 'MP:0001191', 'abnormal skin condition', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812572, 'HP:0010781', 'Skin dimple', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(812573, 'HP:0010781', 'Skin dimple', 'MP:0001197', 'oily skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812574, 'HP:0010781', 'Skin dimple', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812575, 'HP:0010781', 'Skin dimple', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812576, 'HP:0010781', 'Skin dimple', 'MP:0010206', 'pigment incontinence', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812577, 'HP:0010781', 'Skin dimple', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812578, 'HP:0010781', 'Skin dimple', 'MP:0003941', 'abnormal skin development', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812579, 'HP:0010781', 'Skin dimple', 'MP:0002095', 'abnormal skin pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812580, 'HP:0010781', 'Skin dimple', 'MP:0001198', 'tight skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812581, 'HP:0010781', 'Skin dimple', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812582, 'HP:0010781', 'Skin dimple', 'MP:0010300', 'increased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812583, 'HP:0010781', 'Skin dimple', 'MP:0001213', 'abnormal skin cell number', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812584, 'HP:0010781', 'Skin dimple', 'MP:0009932', 'skin fibrosis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812585, 'HP:0010781', 'Skin dimple', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812586, 'HP:0010781', 'Skin dimple', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812587, 'HP:0010781', 'Skin dimple', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812588, 'HP:0010781', 'Skin dimple', 'MP:0002015', 'epithelioid cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812589, 'HP:0010781', 'Skin dimple', 'MP:0003717', 'pallor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812590, 'HP:0010781', 'Skin dimple', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812591, 'HP:0010781', 'Skin dimple', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812592, 'HP:0010781', 'Skin dimple', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812593, 'HP:0010781', 'Skin dimple', 'MP:0009563', 'dyskeratosis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812594, 'HP:0010781', 'Skin dimple', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812595, 'HP:0010781', 'Skin dimple', 'MP:0011160', 'dermal-epidermal separation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812596, 'HP:0010781', 'Skin dimple', 'MP:0000574', 'abnormal foot pad morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812597, 'HP:0010781', 'Skin dimple', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812598, 'HP:0010781', 'Skin dimple', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812599, 'HP:0010781', 'Skin dimple', 'MP:0005421', 'loose skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812600, 'HP:0010781', 'Skin dimple', 'MP:0009385', 'abnormal dermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812601, 'HP:0010781', 'Skin dimple', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812602, 'HP:0010781', 'Skin dimple', 'MP:0012248', 'absent dermatome', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812603, 'HP:0010781', 'Skin dimple', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812604, 'HP:0010781', 'Skin dimple', 'MP:0009379', 'abnormal foot pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812605, 'HP:0010781', 'Skin dimple', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812606, 'HP:0010781', 'Skin dimple', 'MP:0001210', 'skin ridges', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812607, 'HP:0010781', 'Skin dimple', 'MP:0011239', 'abnormal skin coloration', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812608, 'HP:0010781', 'Skin dimple', 'MP:0013406', 'abnormal epidermal immune compartment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812609, 'HP:0010781', 'Skin dimple', 'MP:0010016', 'variable depigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812610, 'HP:0010781', 'Skin dimple', 'MP:0001193', 'psoriasis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812611, 'HP:0010781', 'Skin dimple', 'MP:0009607', 'decreased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812612, 'HP:0010781', 'Skin dimple', 'MP:0003652', 'abnormal skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812613, 'HP:0010781', 'Skin dimple', 'MP:0009441', 'delayed skin barrier formation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812614, 'HP:0010781', 'Skin dimple', 'MP:0000377', 'abnormal hair follicle morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812615, 'HP:0010781', 'Skin dimple', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812616, 'HP:0010781', 'Skin dimple', 'MP:0001212', 'skin lesions', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812617, 'HP:0010781', 'Skin dimple', 'MP:0014273', 'abnormal skin vasculature morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812618, 'HP:0010781', 'Skin dimple', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812619, 'HP:0010781', 'Skin dimple', 'MP:0009604', 'increased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812620, 'HP:0010781', 'Skin dimple', 'MP:0003940', 'abnormal dermatome morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812621, 'HP:0010781', 'Skin dimple', 'MP:0008816', 'petechiae', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812622, 'HP:0010781', 'Skin dimple', 'MP:0009827', 'skin detachment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812623, 'HP:0010781', 'Skin dimple', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812624, 'HP:0010781', 'Skin dimple', 'MP:0001230', 'epidermal desquamation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812625, 'HP:0010781', 'Skin dimple', 'MP:0008854', 'bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812626, 'HP:0010781', 'Skin dimple', 'MP:0005174', 'abnormal tail pigmentation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812627, 'HP:0010781', 'Skin dimple', 'MP:0001209', 'spontaneous skin ulceration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812628, 'HP:0010781', 'Skin dimple', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812629, 'HP:0010781', 'Skin dimple', 'MP:0001208', 'blistering', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812630, 'HP:0010781', 'Skin dimple', 'MP:0031309', 'skin cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812631, 'HP:0010781', 'Skin dimple', 'MP:0003653', 'decreased skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812632, 'HP:0010781', 'Skin dimple', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812633, 'HP:0010781', 'Skin dimple', 'MP:0009603', 'absent keratohyalin granules', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812634, 'HP:0010781', 'Skin dimple', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812635, 'HP:0010781', 'Skin dimple', 'MP:0001201', 'translucent skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812636, 'HP:0010781', 'Skin dimple', 'MP:0003196', 'calcified skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812637, 'HP:0010781', 'Skin dimple', 'MP:0003853', 'dry skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812638, 'HP:0010781', 'Skin dimple', 'MP:0004241', 'acantholysis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812639, 'HP:0010781', 'Skin dimple', 'MP:0011515', 'purpura', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812640, 'HP:0010781', 'Skin dimple', 'MP:0003705', 'abnormal hypodermis morphology', 0.4230769230769231, 6.509554027552121, 1.6595306832293713, 'UPHENO:0002635', 'abnormal integument'),
(812641, 'HP:0010781', 'Skin dimple', 'MP:0008856', 'fetal bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812642, 'HP:0010781', 'Skin dimple', 'MP:0002060', 'abnormal skin morphology', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812643, 'HP:0010781', 'Skin dimple', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(812644, 'HP:0010781', 'Skin dimple', 'MP:0031103', 'skin rash', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812645, 'HP:0010781', 'Skin dimple', 'MP:0009931', 'abnormal skin appearance', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812646, 'HP:0010781', 'Skin dimple', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812647, 'HP:0010781', 'Skin dimple', 'MP:0001195', 'flaky skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(812648, 'HP:0033429', 'Neuroinflammation', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812649, 'HP:0033429', 'Neuroinflammation', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812650, 'HP:0033429', 'Neuroinflammation', 'MP:0008703', 'decreased interleukin-5 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812651, 'HP:0033429', 'Neuroinflammation', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812652, 'HP:0033429', 'Neuroinflammation', 'MP:0002420', 'abnormal adaptive immunity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812653, 'HP:0033429', 'Neuroinflammation', 'MP:0008696', 'increased interleukin-3 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812654, 'HP:0033429', 'Neuroinflammation', 'MP:0002419', 'abnormal innate immunity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812655, 'HP:0033429', 'Neuroinflammation', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812656, 'HP:0033429', 'Neuroinflammation', 'MP:0008666', 'increased interleukin-12a secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812657, 'HP:0033429', 'Neuroinflammation', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812658, 'HP:0033429', 'Neuroinflammation', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812659, 'HP:0033429', 'Neuroinflammation', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812660, 'HP:0033429', 'Neuroinflammation', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812661, 'HP:0033429', 'Neuroinflammation', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812662, 'HP:0033429', 'Neuroinflammation', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812663, 'HP:0033429', 'Neuroinflammation', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812664, 'HP:0033429', 'Neuroinflammation', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812665, 'HP:0033429', 'Neuroinflammation', 'MP:0003725', 'increased autoantibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812666, 'HP:0033429', 'Neuroinflammation', 'MP:0008564', 'increased interferon-beta secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812667, 'HP:0033429', 'Neuroinflammation', 'MP:0031222', 'decreased CXCL10 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812668, 'HP:0033429', 'Neuroinflammation', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812669, 'HP:0033429', 'Neuroinflammation', 'MP:0008711', 'increased interleukin-9 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812670, 'HP:0033429', 'Neuroinflammation', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812671, 'HP:0033429', 'Neuroinflammation', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812672, 'HP:0033429', 'Neuroinflammation', 'MP:0002500', 'granulomatous inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812673, 'HP:0033429', 'Neuroinflammation', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812674, 'HP:0033429', 'Neuroinflammation', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812675, 'HP:0033429', 'Neuroinflammation', 'MP:0008706', 'decreased interleukin-6 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812676, 'HP:0033429', 'Neuroinflammation', 'MP:0008688', 'decreased interleukin-2 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812677, 'HP:0033429', 'Neuroinflammation', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812678, 'HP:0033429', 'Neuroinflammation', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812679, 'HP:0033429', 'Neuroinflammation', 'MP:0008744', 'abnormal B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812680, 'HP:0033429', 'Neuroinflammation', 'MP:0012554', 'increased serum complement activity', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812681, 'HP:0033429', 'Neuroinflammation', 'MP:0004796', 'increased anti-histone antibody level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812682, 'HP:0033429', 'Neuroinflammation', 'MP:0030132', 'periodontium inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812683, 'HP:0033429', 'Neuroinflammation', 'MP:0020154', 'impaired humoral immune response', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812684, 'HP:0033429', 'Neuroinflammation', 'MP:0008700', 'decreased interleukin-4 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812685, 'HP:0033429', 'Neuroinflammation', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812686, 'HP:0033429', 'Neuroinflammation', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812687, 'HP:0033429', 'Neuroinflammation', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812688, 'HP:0033429', 'Neuroinflammation', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812689, 'HP:0033429', 'Neuroinflammation', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812690, 'HP:0033429', 'Neuroinflammation', 'MP:0008687', 'increased interleukin-2 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812691, 'HP:0033429', 'Neuroinflammation', 'MP:0012565', 'perivasculitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812692, 'HP:0033429', 'Neuroinflammation', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812693, 'HP:0033429', 'Neuroinflammation', 'MP:0002471', 'abnormal complement pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812694, 'HP:0033429', 'Neuroinflammation', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812695, 'HP:0033429', 'Neuroinflammation', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812696, 'HP:0033429', 'Neuroinflammation', 'MP:0011717', 'increased interleukin-8 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812697, 'HP:0033429', 'Neuroinflammation', 'MP:0003009', 'abnormal cytokine secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812698, 'HP:0033429', 'Neuroinflammation', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812699, 'HP:0033429', 'Neuroinflammation', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812700, 'HP:0033429', 'Neuroinflammation', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812701, 'HP:0033429', 'Neuroinflammation', 'MP:0030129', 'tongue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812702, 'HP:0033429', 'Neuroinflammation', 'MP:0008670', 'decreased interleukin-12b secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812703, 'HP:0033429', 'Neuroinflammation', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812704, 'HP:0033429', 'Neuroinflammation', 'MP:0008691', 'decreased interleukin-23 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812705, 'HP:0033429', 'Neuroinflammation', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812706, 'HP:0033429', 'Neuroinflammation', 'MP:0008562', 'increased interferon-alpha secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812707, 'HP:0033429', 'Neuroinflammation', 'MP:0005025', 'abnormal response to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812708, 'HP:0033429', 'Neuroinflammation', 'MP:0002498', 'abnormal acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812709, 'HP:0033429', 'Neuroinflammation', 'MP:0013971', 'blood in lymph vessels', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812710, 'HP:0033429', 'Neuroinflammation', 'MP:0020142', 'increased anti-sperm antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812711, 'HP:0033429', 'Neuroinflammation', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812712, 'HP:0033429', 'Neuroinflammation', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812713, 'HP:0033429', 'Neuroinflammation', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812714, 'HP:0033429', 'Neuroinflammation', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812715, 'HP:0033429', 'Neuroinflammation', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812716, 'HP:0033429', 'Neuroinflammation', 'MP:0008693', 'increased interleukin-23a secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812717, 'HP:0033429', 'Neuroinflammation', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812718, 'HP:0033429', 'Neuroinflammation', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812719, 'HP:0033429', 'Neuroinflammation', 'MP:0005088', 'increased acute inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812720, 'HP:0033429', 'Neuroinflammation', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812721, 'HP:0033429', 'Neuroinflammation', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812722, 'HP:0033429', 'Neuroinflammation', 'MP:0009062', 'impaired lectin complement pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812723, 'HP:0033429', 'Neuroinflammation', 'MP:0008568', 'abnormal interleukin secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812724, 'HP:0033429', 'Neuroinflammation', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812725, 'HP:0033429', 'Neuroinflammation', 'MP:0030153', 'dental pulp inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812726, 'HP:0033429', 'Neuroinflammation', 'MP:0008676', 'decreased interleukin-15 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812727, 'HP:0033429', 'Neuroinflammation', 'MP:0005364', 'increased susceptibility to prion infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812728, 'HP:0033429', 'Neuroinflammation', 'MP:0005005', 'abnormal self tolerance', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812729, 'HP:0033429', 'Neuroinflammation', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812730, 'HP:0033429', 'Neuroinflammation', 'MP:0002406', 'increased susceptibility to infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812731, 'HP:0033429', 'Neuroinflammation', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812732, 'HP:0033429', 'Neuroinflammation', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812733, 'HP:0033429', 'Neuroinflammation', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812734, 'HP:0033429', 'Neuroinflammation', 'MP:0008705', 'increased interleukin-6 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812735, 'HP:0033429', 'Neuroinflammation', 'MP:0005671', 'abnormal response to transplant', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812736, 'HP:0033429', 'Neuroinflammation', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812737, 'HP:0033429', 'Neuroinflammation', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812738, 'HP:0033429', 'Neuroinflammation', 'MP:0008663', 'increased interleukin-12 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812739, 'HP:0033429', 'Neuroinflammation', 'MP:0008709', 'decreased interleukin-7 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812740, 'HP:0033429', 'Neuroinflammation', 'MP:0008712', 'decreased interleukin-9 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812741, 'HP:0033429', 'Neuroinflammation', 'MP:0003726', 'decreased autoantibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812742, 'HP:0033429', 'Neuroinflammation', 'MP:0008664', 'decreased interleukin-12 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812743, 'HP:0033429', 'Neuroinflammation', 'MP:0020001', 'decreased response to antigen', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812744, 'HP:0033429', 'Neuroinflammation', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812745, 'HP:0033429', 'Neuroinflammation', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812746, 'HP:0033429', 'Neuroinflammation', 'MP:0008555', 'abnormal interferon secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812747, 'HP:0033429', 'Neuroinflammation', 'MP:0008708', 'increased interleukin-7 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812748, 'HP:0033429', 'Neuroinflammation', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812749, 'HP:0033429', 'Neuroinflammation', 'MP:0020155', 'enhanced humoral immune response', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812750, 'HP:0033429', 'Neuroinflammation', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812751, 'HP:0033429', 'Neuroinflammation', 'MP:0002418', 'increased susceptibility to viral infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812752, 'HP:0033429', 'Neuroinflammation', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812753, 'HP:0033429', 'Neuroinflammation', 'MP:0008672', 'increased interleukin-13 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812754, 'HP:0033429', 'Neuroinflammation', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812755, 'HP:0033429', 'Neuroinflammation', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812756, 'HP:0033429', 'Neuroinflammation', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812757, 'HP:0033429', 'Neuroinflammation', 'MP:0008702', 'increased interleukin-5 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812758, 'HP:0033429', 'Neuroinflammation', 'MP:0008699', 'increased interleukin-4 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812759, 'HP:0033429', 'Neuroinflammation', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812760, 'HP:0033429', 'Neuroinflammation', 'MP:0008651', 'increased interleukin-1 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812761, 'HP:0033429', 'Neuroinflammation', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812762, 'HP:0033429', 'Neuroinflammation', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812763, 'HP:0033429', 'Neuroinflammation', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812764, 'HP:0033429', 'Neuroinflammation', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812765, 'HP:0033429', 'Neuroinflammation', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812766, 'HP:0033429', 'Neuroinflammation', 'MP:0008747', 'abnormal T cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812767, 'HP:0033429', 'Neuroinflammation', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812768, 'HP:0033429', 'Neuroinflammation', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812769, 'HP:0033429', 'Neuroinflammation', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812770, 'HP:0033429', 'Neuroinflammation', 'MP:0008660', 'increased interleukin-10 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812771, 'HP:0033429', 'Neuroinflammation', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812772, 'HP:0033429', 'Neuroinflammation', 'MP:0008679', 'decreased interleukin-16 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812773, 'HP:0033429', 'Neuroinflammation', 'MP:0008685', 'decreased interleukin-18 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812774, 'HP:0033429', 'Neuroinflammation', 'MP:0001837', 'defective assembly of class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812775, 'HP:0033429', 'Neuroinflammation', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812776, 'HP:0033429', 'Neuroinflammation', 'MP:0005087', 'decreased acute inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812777, 'HP:0033429', 'Neuroinflammation', 'MP:0004751', 'increased length of allograft survival', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812778, 'HP:0033429', 'Neuroinflammation', 'MP:0008697', 'decreased interleukin-3 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812779, 'HP:0033429', 'Neuroinflammation', 'MP:0008748', 'abnormal central T cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812780, 'HP:0033429', 'Neuroinflammation', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812781, 'HP:0033429', 'Neuroinflammation', 'MP:0008661', 'decreased interleukin-10 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812782, 'HP:0033429', 'Neuroinflammation', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812783, 'HP:0033429', 'Neuroinflammation', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812784, 'HP:0033429', 'Neuroinflammation', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812785, 'HP:0033429', 'Neuroinflammation', 'MP:0012553', 'decreased serum complement activity', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812786, 'HP:0033429', 'Neuroinflammation', 'MP:0001835', 'abnormal antigen presentation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812787, 'HP:0033429', 'Neuroinflammation', 'MP:0008673', 'decreased interleukin-13 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812788, 'HP:0033429', 'Neuroinflammation', 'MP:0031066', 'cytokine storm', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812789, 'HP:0033429', 'Neuroinflammation', 'MP:0005001', 'abnormal clonal deletion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812790, 'HP:0033429', 'Neuroinflammation', 'MP:0009058', 'decreased interleukin-21 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812791, 'HP:0033429', 'Neuroinflammation', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812792, 'HP:0033429', 'Neuroinflammation', 'MP:0008669', 'increased interleukin-12b secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812793, 'HP:0033429', 'Neuroinflammation', 'MP:0008684', 'increased interleukin-18 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812794, 'HP:0033429', 'Neuroinflammation', 'MP:0001793', 'abnormal susceptibility to infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812795, 'HP:0033429', 'Neuroinflammation', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812796, 'HP:0033429', 'Neuroinflammation', 'MP:0001846', 'increased inflammatory response', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812797, 'HP:0033429', 'Neuroinflammation', 'MP:0005000', 'abnormal immune tolerance', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812798, 'HP:0033429', 'Neuroinflammation', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812799, 'HP:0033429', 'Neuroinflammation', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812800, 'HP:0033429', 'Neuroinflammation', 'MP:0002473', 'impaired complement classical pathway', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812801, 'HP:0033429', 'Neuroinflammation', 'MP:0001790', 'abnormal immune system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812802, 'HP:0033429', 'Neuroinflammation', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812803, 'HP:0033429', 'Neuroinflammation', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812804, 'HP:0033429', 'Neuroinflammation', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812805, 'HP:0033429', 'Neuroinflammation', 'MP:0002499', 'chronic inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812806, 'HP:0033429', 'Neuroinflammation', 'MP:0002409', 'decreased susceptibility to infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812807, 'HP:0033429', 'Neuroinflammation', 'MP:0008678', 'increased interleukin-16 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812808, 'HP:0033429', 'Neuroinflammation', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812809, 'HP:0033429', 'Neuroinflammation', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812810, 'HP:0033429', 'Neuroinflammation', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812811, 'HP:0033429', 'Neuroinflammation', 'MP:0020000', 'abnormal response to antigen', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812812, 'HP:0033429', 'Neuroinflammation', 'MP:0003777', 'lip inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812813, 'HP:0033429', 'Neuroinflammation', 'MP:0008722', 'abnormal chemokine secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812814, 'HP:0033429', 'Neuroinflammation', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812815, 'HP:0033429', 'Neuroinflammation', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812816, 'HP:0033429', 'Neuroinflammation', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812817, 'HP:0033429', 'Neuroinflammation', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812818, 'HP:0033429', 'Neuroinflammation', 'MP:0008690', 'increased interleukin-23 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812819, 'HP:0033429', 'Neuroinflammation', 'MP:0005044', 'sepsis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812820, 'HP:0033429', 'Neuroinflammation', 'MP:0008682', 'decreased interleukin-17 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812821, 'HP:0033429', 'Neuroinflammation', 'MP:0008565', 'decreased interferon-beta secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812822, 'HP:0033429', 'Neuroinflammation', 'MP:0001845', 'abnormal inflammatory response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812823, 'HP:0033429', 'Neuroinflammation', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812824, 'HP:0033429', 'Neuroinflammation', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812825, 'HP:0033429', 'Neuroinflammation', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812826, 'HP:0033429', 'Neuroinflammation', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812827, 'HP:0033429', 'Neuroinflammation', 'MP:0011718', 'decreased interleukin-8 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812828, 'HP:0033429', 'Neuroinflammation', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812829, 'HP:0033429', 'Neuroinflammation', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812830, 'HP:0033429', 'Neuroinflammation', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812831, 'HP:0033429', 'Neuroinflammation', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812832, 'HP:0033429', 'Neuroinflammation', 'MP:0010368', 'abnormal lymphatic system physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812833, 'HP:0033429', 'Neuroinflammation', 'MP:0001800', 'abnormal humoral immune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812834, 'HP:0033429', 'Neuroinflammation', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812835, 'HP:0033429', 'Neuroinflammation', 'MP:0031223', 'increased CXCL10 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812836, 'HP:0033429', 'Neuroinflammation', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812837, 'HP:0033429', 'Neuroinflammation', 'MP:0008567', 'decreased interferon-gamma secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812838, 'HP:0033429', 'Neuroinflammation', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812839, 'HP:0033429', 'Neuroinflammation', 'MP:0003762', 'abnormal immune organ physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812840, 'HP:0033429', 'Neuroinflammation', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812841, 'HP:0033429', 'Neuroinflammation', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812842, 'HP:0033429', 'Neuroinflammation', 'MP:0008563', 'decreased interferon-alpha secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812843, 'HP:0033429', 'Neuroinflammation', 'MP:0009057', 'increased interleukin-21 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812844, 'HP:0033429', 'Neuroinflammation', 'MP:0020002', 'increased response to antigen', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812845, 'HP:0033429', 'Neuroinflammation', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812846, 'HP:0033429', 'Neuroinflammation', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812847, 'HP:0033429', 'Neuroinflammation', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812848, 'HP:0033429', 'Neuroinflammation', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812849, 'HP:0033429', 'Neuroinflammation', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812850, 'HP:0033429', 'Neuroinflammation', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812851, 'HP:0033429', 'Neuroinflammation', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812852, 'HP:0033429', 'Neuroinflammation', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812853, 'HP:0033429', 'Neuroinflammation', 'MP:0001844', 'autoimmune response', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812854, 'HP:0033429', 'Neuroinflammation', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812855, 'HP:0033429', 'Neuroinflammation', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812856, 'HP:0033429', 'Neuroinflammation', 'MP:0008681', 'increased interleukin-17 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812857, 'HP:0033429', 'Neuroinflammation', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812858, 'HP:0033429', 'Neuroinflammation', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812859, 'HP:0033429', 'Neuroinflammation', 'MP:0001819', 'abnormal immune cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812860, 'HP:0033429', 'Neuroinflammation', 'MP:0008675', 'increased interleukin-15 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812861, 'HP:0033429', 'Neuroinflammation', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812862, 'HP:0033429', 'Neuroinflammation', 'MP:0003865', 'lymph node inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812863, 'HP:0033429', 'Neuroinflammation', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812864, 'HP:0033429', 'Neuroinflammation', 'MP:0002472', 'impaired complement alternative pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812865, 'HP:0033429', 'Neuroinflammation', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812866, 'HP:0033429', 'Neuroinflammation', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812867, 'HP:0033429', 'Neuroinflammation', 'MP:0008652', 'decreased interleukin-1 secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812868, 'HP:0033429', 'Neuroinflammation', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812869, 'HP:0033429', 'Neuroinflammation', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812870, 'HP:0033429', 'Neuroinflammation', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812871, 'HP:0033429', 'Neuroinflammation', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812872, 'HP:0033429', 'Neuroinflammation', 'MP:0004752', 'decreased length of allograft survival', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812873, 'HP:0033429', 'Neuroinflammation', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812874, 'HP:0033429', 'Neuroinflammation', 'MP:0005043', 'defective assembly of class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812875, 'HP:0033429', 'Neuroinflammation', 'MP:0001876', 'decreased inflammatory response', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812876, 'HP:0033429', 'Neuroinflammation', 'MP:0008566', 'increased interferon-gamma secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812877, 'HP:0030529', 'Ring scotoma', 'MP:0004021', 'abnormal rod electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812878, 'HP:0030529', 'Ring scotoma', 'MP:0005253', 'abnormal eye physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812879, 'HP:0030529', 'Ring scotoma', 'MP:0010748', 'abnormal visual evoked potential', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812880, 'HP:0030529', 'Ring scotoma', 'MP:0013145', 'eye discharge', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812881, 'HP:0030529', 'Ring scotoma', 'MP:0013468', 'chromodacryorrhea', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812882, 'HP:0030529', 'Ring scotoma', 'MP:0006150', 'double vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812883, 'HP:0030529', 'Ring scotoma', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812884, 'HP:0030529', 'Ring scotoma', 'MP:0014157', 'alacrima', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812885, 'HP:0030529', 'Ring scotoma', 'MP:0001337', 'dry eyes', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812886, 'HP:0030529', 'Ring scotoma', 'MP:0012035', 'abnormal b-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812887, 'HP:0030529', 'Ring scotoma', 'MP:0020219', 'increased tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812888, 'HP:0030529', 'Ring scotoma', 'MP:0012040', 'abnormal c-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812889, 'HP:0030529', 'Ring scotoma', 'MP:0020439', 'absent b-wave', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812890, 'HP:0030529', 'Ring scotoma', 'MP:0011832', 'abnormal visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812891, 'HP:0030529', 'Ring scotoma', 'MP:0020860', 'abnormal cornea physiology', 0.42857142857142855, 8.795504987450572, 1.9415205735399295, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812892, 'HP:0030529', 'Ring scotoma', 'MP:0012034', 'abnormal a-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812893, 'HP:0030529', 'Ring scotoma', 'MP:0020218', 'abnormal tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812894, 'HP:0030529', 'Ring scotoma', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812895, 'HP:0030529', 'Ring scotoma', 'MP:0006190', 'retina ischemia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812896, 'HP:0030529', 'Ring scotoma', 'MP:0008145', 'hemeralopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812897, 'HP:0030529', 'Ring scotoma', 'MP:0003100', 'myopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812898, 'HP:0030529', 'Ring scotoma', 'MP:0006153', 'hypermetropia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812899, 'HP:0030529', 'Ring scotoma', 'MP:0020974', 'abnormal FO-wave shape', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812900, 'HP:0030529', 'Ring scotoma', 'MP:0002090', 'abnormal vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812901, 'HP:0030529', 'Ring scotoma', 'MP:0012033', 'abnormal ERG implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812902, 'HP:0030529', 'Ring scotoma', 'MP:0004022', 'abnormal cone electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812903, 'HP:0030529', 'Ring scotoma', 'MP:0014132', 'abnormal tear film physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812904, 'HP:0030529', 'Ring scotoma', 'MP:0005257', 'abnormal intraocular pressure', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812905, 'HP:0030529', 'Ring scotoma', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812906, 'HP:0030529', 'Ring scotoma', 'MP:0005551', 'abnormal eye electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812907, 'HP:0030529', 'Ring scotoma', 'MP:0006152', 'tunnel vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812908, 'HP:0030529', 'Ring scotoma', 'MP:0003011', 'delayed dark adaptation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812909, 'HP:0030529', 'Ring scotoma', 'MP:0020220', 'decreased tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812910, 'HP:0030529', 'Ring scotoma', 'MP:0012032', 'abnormal ERG latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812911, 'HP:0030529', 'Ring scotoma', 'MP:0003096', 'increased corneal light-scattering', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(812912, 'HP:0003199', 'Decreased muscle mass', 'MP:0004016', 'decreased bone mass', 0.4117647058823529, 10.48475063655155, 2.0777993796585514, 'UPHENO:0054261', 'decreased anatomical entity mass'),
(812913, 'HP:0003199', 'Decreased muscle mass', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(812914, 'HP:0003199', 'Decreased muscle mass', 'MP:0003397', 'increased muscle weight', 0.46875, 12.637520916954795, 2.4338935740542476, 'UPHENO:0010756', 'abnormality of muscle organ mass'),
(812915, 'HP:0003199', 'Decreased muscle mass', 'MP:0000752', 'dystrophic muscle', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(812916, 'HP:0003199', 'Decreased muscle mass', 'MP:0000733', 'abnormal muscle development', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(812917, 'HP:0003199', 'Decreased muscle mass', 'MP:0004232', 'decreased muscle weight', 0.6333333333333333, 13.944182255188847, 2.97175292181, 'UPHENO:0054249', 'decreased muscle organ mass'),
(812918, 'HP:0003199', 'Decreased muscle mass', 'MP:0004233', 'abnormal muscle weight', 0.5172413793103449, 12.637520916954795, 2.5566870653541143, 'UPHENO:0010756', 'abnormality of muscle organ mass'),
(812919, 'HP:0006603', 'Flared, irregular rib ends', 'MP:0010104', 'enlarged thoracic cage', 0.42857142857142855, 11.92532322793753, 2.26071953412475, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(812920, 'HP:0006603', 'Flared, irregular rib ends', 'MP:0010099', 'abnormal thoracic cage shape', 0.4186046511627907, 11.92532322793753, 2.2342774603514033, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(812921, 'HP:0006603', 'Flared, irregular rib ends', 'MP:0004675', 'rib fractures', 0.42857142857142855, 11.297292005324488, 2.200385551150183, 'UPHENO:0083650', 'abnormal rib morphology'),
(812922, 'HP:0006603', 'Flared, irregular rib ends', 'MP:0010103', 'small thoracic cage', 0.42857142857142855, 11.92532322793753, 2.26071953412475, 'UPHENO:0020562', 'abnormal thoracic rib cage morphology'),
(812923, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812924, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812925, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812926, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812927, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812928, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812929, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812930, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812931, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812932, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812933, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812934, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812935, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812936, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812937, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812938, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812939, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812940, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812941, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812942, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812943, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812944, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812945, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812946, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812947, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812948, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812949, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812950, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812951, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812952, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812953, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812954, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812955, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812956, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812957, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812958, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812959, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812960, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812961, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812962, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812963, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812964, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812965, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812966, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812967, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812968, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812969, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812970, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812971, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812972, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812973, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812974, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812975, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812976, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812977, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812978, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812979, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812980, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812981, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812982, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812983, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812984, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812985, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812986, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812987, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812988, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812989, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812990, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812991, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812992, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812993, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812994, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812995, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812996, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812997, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(812998, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(812999, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813000, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813001, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813002, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813003, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813004, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813005, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813006, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813007, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813008, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813009, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813010, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813011, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813012, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813013, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813014, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813015, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813016, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813017, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813018, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813019, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813020, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813021, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813022, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813023, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813024, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813025, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813026, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813027, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813028, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813029, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813030, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813031, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813032, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813033, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813034, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813035, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813036, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813037, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813038, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813039, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813040, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813041, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813042, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813043, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813044, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813045, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813046, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813047, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813048, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813049, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813050, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813051, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813052, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813053, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813054, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813055, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813056, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813057, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813058, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813059, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813060, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813061, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813062, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813063, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813064, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813065, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813066, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813067, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813068, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813069, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813070, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813071, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813072, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813073, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813074, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813075, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813076, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813077, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813078, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813079, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813080, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813081, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813082, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813083, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813084, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813085, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813086, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813087, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813088, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813089, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813090, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813091, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813092, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813093, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813094, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813095, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813096, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813097, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813098, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813099, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813100, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813101, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813102, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813103, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813104, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813105, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813106, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813107, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813108, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813109, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813110, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813111, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813112, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813113, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813114, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813115, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813116, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813117, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813118, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813119, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813120, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813121, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813122, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813123, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813124, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813125, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813126, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813127, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813128, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813129, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813130, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813131, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813132, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813133, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813134, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813135, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813136, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813137, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813138, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813139, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813140, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813141, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813142, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813143, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813144, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813145, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813146, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813147, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813148, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813149, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813150, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813151, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813152, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813153, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813154, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813155, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813156, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813157, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813158, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813159, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813160, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813161, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813162, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813163, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813164, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813165, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813166, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813167, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813168, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813169, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813170, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813171, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813172, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813173, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813174, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813175, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813176, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813177, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813178, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813179, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813180, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813181, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813182, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813183, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813184, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813185, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813186, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813187, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813188, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813189, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813190, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813191, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813192, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813193, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813194, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813195, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813196, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813197, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813198, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813199, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813200, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813201, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813202, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813203, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813204, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813205, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813206, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813207, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813208, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813209, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813210, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813211, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813212, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813213, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813214, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813215, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813216, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813217, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813218, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813219, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813220, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813221, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813222, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813223, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813224, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813225, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813226, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813227, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813228, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813229, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813230, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813231, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813232, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813233, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813234, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813235, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813236, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813237, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813238, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813239, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813240, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813241, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813242, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813243, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813244, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813245, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813246, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813247, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813248, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813249, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813250, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813251, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813252, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813253, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813254, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813255, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813256, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813257, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813258, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813259, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813260, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813261, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813262, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813263, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813264, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813265, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813266, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813267, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813268, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813269, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813270, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813271, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813272, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813273, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813274, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813275, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813276, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813277, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813278, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813279, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813280, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813281, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813282, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813283, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813284, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813285, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813286, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813287, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813288, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813289, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813290, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813291, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813292, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813293, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813294, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813295, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813296, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813297, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813298, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813299, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813300, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813301, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813302, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813303, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813304, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813305, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813306, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813307, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813308, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813309, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813310, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813311, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813312, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813313, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813314, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813315, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813316, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813317, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813318, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813319, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813320, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813321, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813322, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813323, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813324, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813325, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813326, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813327, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813328, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813329, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813330, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813331, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813332, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813333, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813334, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813335, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813336, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813337, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813338, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813339, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813340, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813341, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813342, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813343, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813344, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813345, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813346, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813347, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813348, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813349, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813350, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813351, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813352, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813353, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813354, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813355, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813356, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813357, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813358, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813359, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813360, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813361, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813362, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813363, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813364, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813365, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813366, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813367, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813368, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813369, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813370, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813371, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813372, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813373, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813374, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813375, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813376, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813377, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813378, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813379, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813380, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813381, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813382, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813383, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813384, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813385, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813386, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813387, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813388, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813389, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813390, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813391, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813392, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813393, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813394, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813395, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813396, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813397, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813398, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813399, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813400, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813401, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813402, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813403, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813404, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813405, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813406, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813407, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813408, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813409, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813410, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813411, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813412, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813413, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813414, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813415, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813416, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813417, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813418, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813419, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813420, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813421, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813422, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813423, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813424, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813425, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813426, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813427, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813428, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813429, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813430, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813431, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813432, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813433, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813434, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813435, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813436, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813437, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813438, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813439, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813440, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813441, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813442, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813443, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813444, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813445, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813446, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813447, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813448, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813449, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813450, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813451, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813452, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813453, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813454, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813455, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813456, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813457, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813458, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813459, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813460, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813461, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813462, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813463, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813464, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813465, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813466, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813467, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813468, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813469, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813470, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813471, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813472, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813473, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813474, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813475, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813476, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813477, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813478, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813479, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813480, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813481, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813482, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813483, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813484, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813485, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813486, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813487, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813488, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813489, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813490, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813491, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813492, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813493, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813494, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813495, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813496, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813497, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813498, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813499, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813500, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813501, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813502, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813503, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813504, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813505, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813506, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813507, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813508, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813509, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813510, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813511, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813512, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813513, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813514, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813515, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813516, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813517, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813518, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813519, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813520, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813521, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813522, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813523, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813524, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813525, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813526, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813527, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813528, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813529, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813530, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813531, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813532, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813533, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813534, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813535, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813536, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813537, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813538, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813539, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813540, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813541, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813542, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813543, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813544, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813545, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813546, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813547, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813548, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813549, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813550, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813551, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813552, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813553, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813554, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813555, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813556, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813557, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813558, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813559, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813560, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813561, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813562, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813563, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813564, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813565, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813566, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813567, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813568, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813569, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813570, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813571, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813572, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813573, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813574, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813575, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813576, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813577, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813578, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813579, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813580, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813581, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813582, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813583, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813584, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813585, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813586, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813587, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813588, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813589, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813590, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813591, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813592, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813593, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813594, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813595, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813596, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813597, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813598, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813599, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813600, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813601, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813602, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813603, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813604, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813605, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813606, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813607, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813608, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813609, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813610, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813611, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813612, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813613, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813614, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813615, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813616, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813617, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813618, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813619, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813620, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813621, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813622, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813623, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813624, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813625, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813626, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813627, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813628, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813629, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813630, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813631, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813632, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813633, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813634, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813635, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813636, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813637, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813638, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813639, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813640, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813641, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813642, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813643, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813644, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813645, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813646, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813647, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813648, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813649, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813650, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813651, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813652, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813653, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813654, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813655, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813656, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813657, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813658, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813659, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813660, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813661, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813662, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813663, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813664, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813665, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813666, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813667, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813668, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813669, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813670, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(813671, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813672, 'HP:0034135', 'Anti-neurofascin-155 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813673, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0008899', 'plush coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(813674, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000397', 'abnormal guard hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813675, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000411', 'shiny fur', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(813676, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0005409', 'darkened coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(813677, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000371', 'diluted coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813678, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0012076', 'abnormal agouti pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813679, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0008237', 'abnormal ventral coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813680, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009928', 'abnormal pinna hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813681, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0002940', 'variable body spotting', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(813682, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009934', 'abnormal hind foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813683, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0001211', 'wrinkled skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(813684, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0002075', 'abnormal coat/hair pigmentation', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813685, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0013117', 'focal hair loss in thorax region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813686, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000373', 'belly spot', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(813687, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009004', 'progressive hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813688, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0001510', 'abnormal coat appearance', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813689, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0002938', 'white spotting', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813690, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0010202', 'focal dorsal hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813691, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0002073', 'abnormal hair growth', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(813692, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0020440', 'abnormal front foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813693, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0005114', 'premature hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813694, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000407', 'abnormal duvet hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813695, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000370', 'head blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813696, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0013115', 'focal hair loss in abdominal region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813697, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0001197', 'oily skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(813698, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000418', 'focal hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813699, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0013116', 'focal hair loss in head/neck region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813700, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0030584', 'skin atrophy', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(813701, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000372', 'irregular coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813702, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0001511', 'disheveled coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(813703, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0005171', 'absent coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813704, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0005366', 'variegated coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(813705, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0011280', 'abnormal flank coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813706, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000426', 'ectopic hair growth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813707, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0004034', 'belly blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813708, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0002671', 'belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813709, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0010203', 'focal ventral hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813710, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000402', 'abnormal zigzag hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813711, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0008812', 'abnormal rostrocaudal coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813712, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009933', 'abnormal tail hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813713, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0020235', 'black belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813714, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009002', 'premature hair regrowth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(813715, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4838709677419355, 9.570057949176055, 2.1518999050174754, 'UPHENO:0002768', 'abnormal strand of hair'),
(813716, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0012017', 'grizzled coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813717, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0003849', 'greasy coat', 0.4090909090909091, 9.570057949176055, 1.9786418843441866, 'UPHENO:0002768', 'abnormal strand of hair'),
(813718, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0010142', 'disorganized hair shaft', 0.4186046511627907, 9.570057949176055, 2.0015171169446777, 'UPHENO:0002768', 'abnormal strand of hair'),
(813719, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(813720, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009932', 'skin fibrosis', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(813721, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0003196', 'calcified skin', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(813722, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0008238', 'abnormal dorsoventral coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(813723, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000405', 'abnormal auchene hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813724, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0000400', 'abnormal awl hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(813725, 'HP:0011363', 'Abnormality of hair growth rate', 'MP:0009659', 'striated fur', 0.41025641025641024, 9.570057949176055, 1.9814584578473484, 'UPHENO:0002768', 'abnormal strand of hair'),
(813726, 'HP:0033111', '3-hydroxyisovaleric aciduria', 'MP:0011473', 'increased urine glycosaminoglycan level', 0.4230769230769231, 9.50911518495075, 2.005763493942646, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(813727, 'HP:0033111', '3-hydroxyisovaleric aciduria', 'MP:0011765', 'oroticaciduria', 0.41379310344827586, 10.430558536187952, 2.077520923453749, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(813728, 'HP:0033111', '3-hydroxyisovaleric aciduria', 'MP:0030612', 'organic aciduria', 0.5454545454545454, 10.430558536187952, 2.385245388884219, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(813729, 'HP:0033111', '3-hydroxyisovaleric aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.43636363636363634, 10.430558536187952, 2.133428333025214, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(813730, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0010874', 'abnormal bone volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813731, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813732, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0013304', 'osteophytes', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813733, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030804', 'abnormal synovial joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813734, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0002113', 'abnormal skeleton development', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813735, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030878', 'abnormal fibrous joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813736, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813737, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0002114', 'abnormal axial skeleton morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813738, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813739, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0005422', 'osteosclerosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813740, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0005504', 'abnormal ligament morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813741, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0002937', 'synovial hyperemia', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813742, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813743, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813744, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0003795', 'abnormal bone structure', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813745, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0000566', 'synostosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813746, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813747, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0010122', 'abnormal bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813748, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0031348', 'bone fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813749, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0009877', 'exostosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813750, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030818', 'abnormal girdle joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813751, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813752, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0005508', 'abnormal skeleton morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813753, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0002932', 'abnormal joint morphology', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(813754, 'HP:0005059', 'Arthralgia/arthritis', 'MP:0030222', 'hyperostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(813755, 'HP:0033990', 'Cartilaginous tracheobronchomalacia', 'MP:0013497', 'trachea occlusion', 0.40425531914893614, 12.732678149995134, 2.2687557976007398, 'UPHENO:0021304', 'abnormal trachea morphology'),
(813756, 'HP:0033990', 'Cartilaginous tracheobronchomalacia', 'MP:0013499', 'trachea fibrosis', 0.41304347826086957, 12.732678149995134, 2.29328360013544, 'UPHENO:0021304', 'abnormal trachea morphology'),
(813757, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813758, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813759, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000556', 'abnormal hindlimb morphology', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(813760, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813761, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813762, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813763, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813764, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813765, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813766, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813767, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813768, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003854', 'abnormal forelimb stylopod morphology', 0.44, 7.310231061031986, 1.7934608071697786, 'UPHENO:0002880', 'abnormal arm'),
(813769, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813770, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813771, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813772, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813773, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813774, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813775, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813776, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813777, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813778, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813779, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813780, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813781, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813782, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813783, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813784, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813785, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813786, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003855', 'abnormal forelimb zeugopod morphology', 0.4583333333333333, 7.310231061031986, 1.830443271352505, 'UPHENO:0002880', 'abnormal arm'),
(813787, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0006279', 'abnormal limb development', 0.47619047619047616, 5.594289979986924, 1.632160411699041, 'UPHENO:0002830', 'abnormal limb'),
(813788, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813789, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813790, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813791, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813792, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813793, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813794, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813795, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813796, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0008909', 'supination', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(813797, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000572', 'abnormal autopod morphology', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(813798, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813799, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813800, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813801, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011685', 'abnormal limb paddle morphology', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(813802, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813803, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813804, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813805, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813806, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813807, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813808, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813809, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813810, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813811, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0006280', 'abnormal digit development', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(813812, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013133', 'pale limbs', 0.47619047619047616, 5.594289979986924, 1.632160411699041, 'UPHENO:0002830', 'abnormal limb'),
(813813, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813814, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813815, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813816, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031291', 'pes valgus', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(813817, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813818, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813819, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813820, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813821, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813822, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813823, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813824, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813825, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813826, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813827, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813828, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813829, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013069', 'limb wound', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(813830, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0012531', 'delayed limb development', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(813831, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813832, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813833, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813834, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813835, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813836, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813837, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813838, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813839, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813840, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813841, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813842, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813843, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813844, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813845, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813846, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813847, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002109', 'abnormal limb morphology', 0.5, 5.594289979986924, 1.6724667380828422, 'UPHENO:0002830', 'abnormal limb'),
(813848, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813849, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813850, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813851, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813852, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813853, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813854, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000550', 'abnormal forelimb morphology', 0.45454545454545453, 5.594289979986924, 1.5946344665195966, 'UPHENO:0002830', 'abnormal limb'),
(813855, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813856, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813857, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813858, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813859, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813860, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813861, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813862, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0000578', 'ulcerated paws', 0.43478260869565216, 5.594289979986924, 1.5595832748842438, 'UPHENO:0002830', 'abnormal limb'),
(813863, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813864, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813865, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813866, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813867, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813868, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813869, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813870, 'HP:0002817', 'Abnormality of the upper limb', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(813871, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813872, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813873, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813874, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813875, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813876, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813877, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813878, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813879, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813880, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813881, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813882, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813883, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813884, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813885, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813886, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001739', 'abnormal adrenal gland secretion', 0.4838709677419355, 10.708293991368175, 2.276276032573482, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813887, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813888, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813889, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0014030', 'abnormal mucous gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813890, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813891, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813892, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813893, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813894, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813895, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813896, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813897, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813898, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003504', 'thyroid gland inflammation', 0.4857142857142857, 12.548253578857707, 2.4687782452088727, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(813899, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813900, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813901, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813902, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813903, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813904, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813905, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813906, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813907, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813908, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013556', 'abnormal holocrine gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813909, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011911', 'abnormal pancreatic endocrine progenitor cell physiology', 0.45454545454545453, 10.708293991368175, 2.2062199255089703, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813910, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813911, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813912, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813913, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813914, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003501', 'iodide oxidation defect', 0.5862068965517241, 12.548253578857707, 2.7121712312474378, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(813915, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813916, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813917, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813918, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005647', 'abnormal sex gland physiology', 0.40625, 9.740898656800104, 1.9892812971837448, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813919, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813920, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813921, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000611', 'jaundice', 0.40540540540540543, 10.708293991368175, 2.0835547189288985, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813922, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813923, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813924, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813925, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813926, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813927, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002164', 'abnormal gland physiology', 0.5, 9.740898656800104, 2.206909451790003, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813928, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813929, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013557', 'abnormal merocrine gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813930, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0014031', 'abnormal submucosal gland physiology', 0.40625, 9.740898656800104, 1.9892812971837448, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813931, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813932, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813933, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813934, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813935, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013555', 'abnormal apocrine gland physiology', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813936, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813937, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813938, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813939, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813940, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813941, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813942, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813943, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813944, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813945, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813946, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005646', 'abnormal pituitary gland physiology', 0.4166666666666667, 10.708293991368175, 2.1122947623544572, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813947, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813948, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813949, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813950, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813951, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813952, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813953, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.45454545454545453, 10.708293991368175, 2.2062199255089703, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813954, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003433', 'decreased activity of parathyroid', 0.4838709677419355, 10.708293991368175, 2.276276032573482, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813955, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013561', 'abnormal endocrine gland physiology', 0.5555555555555556, 10.708293991368175, 2.439067899306365, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813956, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003503', 'decreased activity of thyroid gland', 0.53125, 12.548253578857707, 2.581910090179005, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(813957, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003432', 'increased activity of parathyroid', 0.4838709677419355, 10.708293991368175, 2.276276032573482, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813958, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813959, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813960, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813961, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813962, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813963, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813964, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002909', 'abnormal adrenal gland physiology', 0.5, 10.708293991368175, 2.313902978883101, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813965, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813966, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813967, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813968, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813969, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003502', 'increased activity of thyroid gland', 0.5862068965517241, 12.548253578857707, 2.7121712312474378, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(813970, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001744', 'hypersecretion of corticosterone', 0.46875, 10.708293991368175, 2.2404269254884954, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813971, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813972, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813973, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813974, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002876', 'abnormal thyroid gland physiology', 0.6071428571428571, 12.548253578857707, 2.7601779888298417, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(813975, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813976, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813977, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813978, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41935483870967744, 9.740898656800104, 2.021111819051514, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813979, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4642857142857143, 9.740898656800104, 2.126631159993945, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813980, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011728', 'abnormal pineal gland physiology', 0.40540540540540543, 10.708293991368175, 2.0835547189288985, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813981, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010147', 'abnormal endocrine pancreas physiology', 0.46875, 10.708293991368175, 2.2404269254884954, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813982, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813983, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813984, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813985, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813986, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813987, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813988, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813989, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813990, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813991, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813992, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.5, 10.708293991368175, 2.313902978883101, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(813993, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002694', 'abnormal pancreas secretion', 0.43333333333333335, 9.740898656800104, 2.0545208893105413, 'UPHENO:0002261', 'abnormality of gland physiology'),
(813994, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813995, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813996, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813997, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813998, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(813999, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814000, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814001, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814002, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814003, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814004, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814005, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814006, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814007, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0001746', 'abnormal pituitary secretion', 0.40540540540540543, 10.708293991368175, 2.0835547189288985, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(814008, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814009, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814010, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002693', 'abnormal pancreas physiology', 0.4482758620689655, 9.740898656800104, 2.0896434487020734, 'UPHENO:0002261', 'abnormality of gland physiology'),
(814011, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814012, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814013, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814014, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814015, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814016, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814017, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814018, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814019, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814020, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814021, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814022, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814023, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0000609', 'abnormal liver physiology', 0.4166666666666667, 10.708293991368175, 2.1122947623544572, 'UPHENO:0002388', 'abnormality of endocrine gland physiology'),
(814024, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814025, 'HP:0033080', 'Abnormal TSH response to thyrotrophin-releasing hormone stimulation test', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814026, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0004556', 'enlarged allantois', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814027, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0003498', 'thyroid gland hyperplasia', 0.46511627906976744, 7.914822368502075, 1.9186747326047344, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814028, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008302', 'thin adrenal cortex', 0.4444444444444444, 11.397693902282326, 2.2506980549037894, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814029, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0009171', 'enlarged pancreatic islets', 0.43478260869565216, 7.914822368502075, 1.8550544781057057, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814030, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0031094', 'organomegaly', 0.45714285714285713, 5.9605885577567275, 1.6507090850740274, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814031, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0009078', 'adrenal gland hyperplasia', 0.6, 15.192109768632433, 3.0191498573571103, 'UPHENO:0001145', 'increased size of the adrenal gland'),
(814032, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0013307', 'increased adrenal gland weight', 0.40476190476190477, 11.397693902282326, 2.147871572925379, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814033, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0001267', 'enlarged chest', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814034, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0005355', 'enlarged thyroid gland', 0.5, 7.914822368502075, 1.989324303438491, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814035, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0000640', 'adrenal gland hypoplasia', 0.4666666666666667, 12.732678149995134, 2.437604658265513, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(814036, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008301', 'adrenal medulla hyperplasia', 0.5116279069767442, 11.397693902282326, 2.4148246883751843, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814037, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0003112', 'enlarged parathyroid gland', 0.5, 7.914822368502075, 1.989324303438491, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814038, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008289', 'abnormal adrenal medulla morphology', 0.42105263157894735, 11.397693902282326, 2.190668622016414, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814039, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0012160', 'expanded anterior visceral endoderm', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814040, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0005491', 'pancreatic islet hyperplasia', 0.40816326530612246, 7.914822368502075, 1.7973702295981608, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814041, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0000642', 'enlarged adrenal glands', 0.6486486486486487, 15.192109768632433, 3.139162543027258, 'UPHENO:0001145', 'increased size of the adrenal gland'),
(814042, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008300', 'enlarged adrenal medulla', 0.55, 11.397693902282326, 2.503743526452995, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814043, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008299', 'adrenal cortical hyperplasia', 0.5238095238095238, 11.397693902282326, 2.4434034901098953, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814044, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0013328', 'visceromegaly', 0.43243243243243246, 5.9605885577567275, 1.6054755709009296, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814045, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0020144', 'small adrenal gland x-zone', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814046, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0009170', 'abnormal pancreatic islet size', 0.4090909090909091, 7.914822368502075, 1.7994115365928876, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814047, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0020145', 'enlarged adrenal gland x-zone', 0.4888888888888889, 11.397693902282326, 2.3605520345424438, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814048, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0011362', 'ectopic adrenal gland', 0.40476190476190477, 11.397693902282326, 2.147871572925379, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814049, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0020169', 'increased thyroid gland weight', 0.45454545454545453, 7.914822368502075, 1.896746301205648, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814050, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0020143', 'abnormal adrenal gland x-zone size', 0.46511627906976744, 11.397693902282326, 2.302444999952384, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814051, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0003113', 'small parathyroid gland', 0.42857142857142855, 7.914822368502075, 1.8417564250893852, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814052, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0001268', 'barrel chest', 0.41025641025641024, 5.9605885577567275, 1.5637677783867745, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814053, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0003493', 'parathyroid gland hyperplasia', 0.46511627906976744, 7.914822368502075, 1.9186747326047344, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814054, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0000639', 'abnormal adrenal gland morphology', 0.4444444444444444, 11.397693902282326, 2.2506980549037894, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814055, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0001264', 'increased body size', 0.42105263157894735, 5.9605885577567275, 1.5842100548862934, 'UPHENO:0065599', 'increased size of the anatomical entity in independent continuant'),
(814056, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0012689', 'abnormal adrenal gland weight', 0.4358974358974359, 11.397693902282326, 2.2289516699894385, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814057, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0013565', 'abnormal adrenal gland capsule morphology', 0.42105263157894735, 11.397693902282326, 2.190668622016414, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814058, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0013366', 'adrenal gland atrophy', 0.4883720930232558, 12.732678149995134, 2.493648868205907, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(814059, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0002768', 'small adrenal glands', 0.525, 12.732678149995134, 2.585470175567192, 'UPHENO:0020671', 'abnormal adrenal gland morphology'),
(814060, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0002951', 'small thyroid gland', 0.42857142857142855, 7.914822368502075, 1.8417564250893852, 'UPHENO:0087376', 'abnormal endocrine gland morphology'),
(814061, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008288', 'abnormal adrenal cortex morphology', 0.41025641025641024, 11.397693902282326, 2.1624007458266665, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814062, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0013310', 'abnormal adrenal gland development', 0.42105263157894735, 11.397693902282326, 2.190668622016414, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814063, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0000646', 'enlarged adrenocortical cells', 0.4074074074074074, 11.397693902282326, 2.1548793291393507, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814064, 'HP:0008221', 'Adrenal hyperplasia', 'MP:0008291', 'abnormal adrenocortical cell morphology', 0.41304347826086957, 11.397693902282326, 2.169733424536617, 'UPHENO:0087384', 'abnormal adrenal gland morphology'),
(814065, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814066, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814067, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814068, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814069, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814070, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814071, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814072, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814073, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814074, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814075, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814076, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814077, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814078, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814079, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814080, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814081, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814082, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814083, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814084, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814085, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814086, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814087, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814088, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814089, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814090, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814091, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814092, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814093, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814094, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814095, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814096, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814097, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814098, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814099, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814100, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814101, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814102, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814103, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814104, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814105, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814106, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814107, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814108, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814109, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814110, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814111, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814112, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814113, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814114, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814115, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814116, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814117, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814118, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814119, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814120, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814121, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814122, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814123, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814124, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814125, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814126, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814127, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814128, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814129, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814130, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814131, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814132, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814133, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814134, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814135, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814136, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814137, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814138, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814139, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814140, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814141, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814142, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814143, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814144, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814145, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814146, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814147, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814148, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814149, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814150, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814151, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814152, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814153, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814154, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814155, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814156, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814157, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814158, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814159, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814160, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814161, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814162, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814163, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814164, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814165, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814166, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814167, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814168, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814169, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814170, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814171, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814172, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814173, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814174, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814175, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814176, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814177, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814178, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814179, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814180, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814181, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814182, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814183, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814184, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814185, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814186, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814187, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814188, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814189, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814190, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814191, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814192, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814193, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814194, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814195, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814196, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814197, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814198, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814199, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814200, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814201, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814202, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814203, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814204, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814205, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814206, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(814207, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(814208, 'HP:0005356', 'Decreased circulating complement factor I concentration', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
